{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:40:11Z","timestamp":1792222811347,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1I1A1A01059638"],"award-info":[{"award-number":["2019R1I1A1A01059638"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2015R1D1A1A01056984"],"award-info":[{"award-number":["2015R1D1A1A01056984"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1D1A1B07048315"],"award-info":[{"award-number":["2018R1D1A1B07048315"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1H1A2079787"],"award-info":[{"award-number":["2019R1H1A2079787"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1F1A1071640"],"award-info":[{"award-number":["2020R1F1A1071640"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Accumulation of lipids and their metabolites induces lipotoxicity in diabetic cardiomyopathy. Lowering ceramide concentration could reduce the impact of metabolic damage to target organs. Adiponectin improves lipotoxicity through its receptors (AdiopRs), which have sequence homology with ceramidase enzymes. Therefore, cardioprotective role of AdipoR agonism by AdipoRon was investigated. Sixteen-week-old male\n                    <jats:italic>db\/m<\/jats:italic>\n                    and\n                    <jats:italic>db\/db<\/jats:italic>\n                    mice were fed a diet containing AdipoRon for four weeks. Phenotypic and metabolic profiles with associated cellular signaling pathways involved in lipid metabolism were investigated in the mice heart and human cardiomyocytes to establish treatment effect of AdipoRon. AdipoRon ameliorated insulin resistance, fibrosis, M1-dominant inflammation, and apoptosis in association with reduced accumulations of free fatty acid, triglycerides, and TLR4-related ceramide in the heart. This resulted in overall reduction in the level of oxidative stress which ameliorated cardiac hypertrophy and its function. AdipoRon increased the expression of AdipoR1 and AdipoR2 via pAMPK\/FoxO1-induced Akt phosphorylation resulting from a decrease in PP2A level. It also increased acid ceramidase activity which reduced ceramide and increased sphingosine-1 phosphate levels in the heart of\n                    <jats:italic>db\/db<\/jats:italic>\n                    mice and cultured human cardiomyocytes. Consistent upregulation of AdipoRs and their downstream regulatory pathways involving pAMPK\/PPAR\u03b1\/PGC-1\u03b1 levels led to lipid metabolism enhancement, thereby improving lipotoxicity-induced peroxisome biogenesis and oxidative stress. AdipoRon might control oxidative stress, inflammation, and apoptosis in the heart through increased AdipoR expression, acid ceramidase activity, and activation of AMPK-PPAR\u03b1\/PGC-1\u03b1 and related downstream pathways, collectively improving cardiac lipid metabolism, hypertrophy, and functional parameters.\n                  <\/jats:p>","DOI":"10.1038\/s41419-022-04726-8","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:04:43Z","timestamp":1648598683000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Adiponectin receptor agonist ameliorates cardiac lipotoxicity via enhancing ceramide metabolism in type 2 diabetic mice"],"prefix":"10.1038","volume":"13","author":[{"given":"Yaeni","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hee","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Nim","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Ah","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hun-Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungjin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1412-9951","authenticated-orcid":false,"given":"Bum Soon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5646-1880","authenticated-orcid":false,"given":"Cheol Whee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"4726_CR1","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.tem.2003.09.008","volume":"14","author":"RH Unger","year":"2003","unstructured":"Unger RH. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab. 2003;14:398\u2013403.","journal-title":"Trends Endocrinol Metab"},{"key":"4726_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cmet.2012.04.006","volume":"15","author":"IJ Goldberg","year":"2012","unstructured":"Goldberg IJ, Trent CM, Schulze PC. Lipid metabolism and toxicity in the heart. Cell Metab. 2012;15:805\u201312.","journal-title":"Cell Metab"},{"key":"4726_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF02938341","volume":"9","author":"S Banerjee","year":"2007","unstructured":"Banerjee S, Peterson LR. Myocardial metabolism and cardiac performance in obesity and insulin resistance. Curr Cardiol Rep. 2007;9:143\u20139.","journal-title":"Curr Cardiol Rep"},{"key":"4726_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/HYPERTENSIONAHA.108.110031","volume":"52","author":"R Harmancey","year":"2008","unstructured":"Harmancey R, Wilson CR, Taegtmeyer H. Adaptation and maladaptation of the heart in obesity. Hypertension 2008;52:181\u20137.","journal-title":"Hypertension"},{"key":"4726_CR5","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.2337\/diab.46.8.1346","volume":"46","author":"B Rodrigues","year":"1997","unstructured":"Rodrigues B, Cam MC, Jian K, Lim F, Sambandam N, Shepherd G. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity. Diabetes 1997;46:1346\u201353.","journal-title":"Diabetes"},{"key":"4726_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.plipres.2005.11.002","volume":"45","author":"SA Summers","year":"2006","unstructured":"Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res. 2006;45:42\u201372.","journal-title":"Prog Lipid Res"},{"key":"4726_CR7","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1172\/JCI57144","volume":"121","author":"BT Bikman","year":"2011","unstructured":"Bikman BT, Summers SA. Ceramides as modulators of cellular and whole-body metabolism. J Clin Invest. 2011;121:4222\u201330.","journal-title":"J Clin Invest"},{"key":"4726_CR8","doi-asserted-by":"publisher","first-page":"21103","DOI":"10.1074\/jbc.M109.080671","volume":"285","author":"KA Rozenova","year":"2010","unstructured":"Rozenova KA, Deevska GM, Karakashian AA, Nikolova-Karakashian MN. Studies on the role of acid sphingomyelinase and ceramide in the regulation of tumor necrosis factor alpha (TNFalpha)-converting enzyme activity and TNFalpha secretion in macrophages. J Biol Chem. 2010;285:21103\u201313.","journal-title":"J Biol Chem"},{"key":"4726_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrm1103","volume":"4","author":"S Spiegel","year":"2003","unstructured":"Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003;4:397\u2013407.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4726_CR10","doi-asserted-by":"publisher","first-page":"19672","DOI":"10.1074\/jbc.M009993200","volume":"276","author":"M Morales-Ruiz","year":"2001","unstructured":"Morales-Ruiz M, Lee MJ, Z\u00f6llner S, Gratton JP, Scotland R, Shiojima I, et al. Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Giprotein\/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem. 2001;276:19672\u20137.","journal-title":"J Biol Chem"},{"key":"4726_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nm1557","volume":"13","author":"T Yamauchi","year":"2007","unstructured":"Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med. 2007;13:332\u20139.","journal-title":"Nat Med"},{"key":"4726_CR12","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/nature08991","volume":"464","author":"M Iwabu","year":"2010","unstructured":"Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, et al. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK\/SIRT1. Nature 2010;464:1313\u20139.","journal-title":"Nature"},{"key":"4726_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nm.2277","volume":"17","author":"WL Holland","year":"2011","unstructured":"Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, Bui HH, et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med. 2011;17:55\u201363.","journal-title":"Nat Med"},{"key":"4726_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/nature21714","volume":"544","author":"I Vasiliauskait\u00e9-Brooks","year":"2017","unstructured":"Vasiliauskait\u00e9-Brooks I, Sounier R, Rochaix P, Bellot G, Fortier M, Hoh F, et al. Structural insights into adiponectin receptors suggest ceramidase activity. Nature 2017;544:120\u20133.","journal-title":"Nature"},{"key":"4726_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412\u20139.","journal-title":"Diabetologia"},{"key":"4726_CR16","doi-asserted-by":"publisher","first-page":"H976","DOI":"10.1152\/ajpheart.00088.2002","volume":"283","author":"LM Semeniuk","year":"2002","unstructured":"Semeniuk LM, Kryski AJ, Severson DL. Echocardiographic assessment of cardiac function in diabetic db\/db and transgenic db\/db-hGLUT4 mice. Am J Physiol Heart Circ Physiol. 2002;283:H976\u201382.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4726_CR17","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/jn\/133.2.468","volume":"133","author":"B Delaney","year":"2003","unstructured":"Delaney B, Nicolosi RJ, Wilson TA, Carlson T, Frazer S, Zheng G-H, et al. Beta-glucan fractions from barley and oats are similarly antiatherogenic in hypercholesterolemic Syrian golden hamsters. J Nutr. 2003;133:468\u201375.","journal-title":"J Nutr"},{"key":"4726_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jdermsci.2014.10.001","volume":"77","author":"KM Joo","year":"2015","unstructured":"Joo KM, Hwang JH, Bae S, Nahm DH, Park HS, Ye YM, et al. Relationship of ceramide-, and free fatty acid-cholesterol ratios in the stratum corneum with skin barrier function of normal, atopic dermatitis lesional and non-lesional skins. J Dermatol Sci. 2015;77:71\u20134.","journal-title":"J Dermatol Sci"},{"key":"4726_CR19","doi-asserted-by":"publisher","first-page":"15523","DOI":"10.1016\/S0021-9258(18)82288-8","volume":"268","author":"RT Dobrowsky","year":"1993","unstructured":"Dobrowsky RT, Kamibayashi C, Mumby MC, Hannun YA. Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem. 1993;268:15523\u201330.","journal-title":"J Biol Chem"},{"key":"4726_CR20","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1089\/scd.2008.0063","volume":"17","author":"K Avery","year":"2008","unstructured":"Avery K, Avery S, Shepherd J, Heath PR, Moore H. Sphingosine-1-phosphate mediates transcriptional regulation of key targets associated with survival, proliferation, and pluripotency in human embryonic stem cells. Stem Cells Dev. 2008;17:1195\u2013205.","journal-title":"Stem Cells Dev"},{"key":"4726_CR21","first-page":"298","volume":"60","author":"B Sauer","year":"2005","unstructured":"Sauer B, Gonska H, Manggau M, Kim DS, Schraut C, Sch\u00e4fer-Korting M, et al. Sphingosine 1-phosphate is involved in cytoprotective actions of calcitriol in human fibroblasts and enhances the intracellular Bcl-2\/Bax rheostat. Pharmazie 2005;60:298\u2013304.","journal-title":"Pharmazie"},{"key":"4726_CR22","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1021\/bi9924415","volume":"39","author":"M Di Paola","year":"2000","unstructured":"Di Paola M, Cocco T, Lorusso M. Ceramide interaction with the respiratory chain of heart mitochondria. Biochemistry 2000;39:6660\u20138.","journal-title":"Biochemistry"},{"key":"4726_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10863-005-6567-7","volume":"37","author":"LJ Siskind","year":"2005","unstructured":"Siskind LJ. Mitochondrial ceramide and the induction of apoptosis. J Bioenerg Biomembr. 2005;37:143\u201353.","journal-title":"J Bioenerg Biomembr"},{"key":"4726_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.cmet.2015.06.007","volume":"22","author":"JY Xia","year":"2015","unstructured":"Xia JY, Holland WL, Kusminski CM, Sun K, Sharma AX, Pearson MJ, et al. Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis. Cell Metab. 2015;22:266\u201378.","journal-title":"Cell Metab"},{"key":"4726_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature13475","volume":"510","author":"M Maceyka","year":"2014","unstructured":"Maceyka M, Spiegel S. Sphingolipid metabolites in inflammatory disease. Nature 2014;510:58\u201367.","journal-title":"Nature"},{"key":"4726_CR26","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1172\/JCI43378","volume":"121","author":"WL Holland","year":"2011","unstructured":"Holland WL, Bikman BT, Wang LP, Yuguang G, Sargent KM, Bulchand S, et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest. 2011;121:1858\u201370.","journal-title":"J Clin Invest"},{"key":"4726_CR27","doi-asserted-by":"publisher","first-page":"30817","DOI":"10.1074\/jbc.M402367200","volume":"279","author":"A Tsuchida","year":"2004","unstructured":"Tsuchida A, Yamauchi T, Ito Y, Hada Y, Maki T, Takekawa S, et al. Insulin\/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem. 2004;279:30817\u201322.","journal-title":"J Biol Chem"},{"key":"4726_CR28","doi-asserted-by":"publisher","first-page":"7468","DOI":"10.1074\/jbc.M110.179242","volume":"286","author":"A Sengupta","year":"2011","unstructured":"Sengupta A, Molkentin JD, Paik JH, DePinho RA, Yutzey KE. FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress. J Biol Chem. 2011;286:7468\u201378.","journal-title":"J Biol Chem"},{"key":"4726_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/cvr\/cvr273","volume":"93","author":"XB Cui","year":"2012","unstructured":"Cui XB, Wang C, Li L, Fan D, Zhou Y, Wu D, et al. Insulin decreases myocardial adiponectin receptor 1 expression via PI3K\/Akt and FoxO1 pathway. Cardiovasc Res. 2012;93:69\u201378.","journal-title":"Cardiovasc Res"},{"key":"4726_CR30","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/aps.2010.73","volume":"31","author":"BL Chen","year":"2010","unstructured":"Chen BL, Ma YD, Meng RS, Xiong ZJ, Wang HN, Zeng JY, et al. Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1\/MuRF1 signaling pathway in vitro. Acta Pharm Sin. 2010;31:798\u2013804.","journal-title":"Acta Pharm Sin"},{"key":"4726_CR31","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1161\/CIRCRESAHA.114.302364","volume":"114","author":"M Kim","year":"2014","unstructured":"Kim M, Hunter RW, Garcia-Menendez L, Gong G, Yang YY, Kolwicz SC Jr, et al. Mutation in the \u03b32-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage. Circ Res. 2014;114:966\u201375.","journal-title":"Circ Res"},{"key":"4726_CR32","doi-asserted-by":"publisher","first-page":"20517","DOI":"10.1073\/pnas.0610290104","volume":"104","author":"YG Ni","year":"2007","unstructured":"Ni YG, Wang N, Cao DJ, Sachan N, Morris DJ, Gerard RD, et al. FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. Proc Natl Acad Sci USA. 2007;104:20517\u201322.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04726-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04726-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04726-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T09:56:33Z","timestamp":1669283793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04726-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["4726"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-04726-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"assertion":[{"value":"19 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal studies were approved by the local ethics committee as indicated in the Methods section.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors have sufficiently contributed to the study and the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The manuscript has not been submitted nor is it under consideration for publication elsewhere. All authors have read and agreed with the submission of the final version of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"282"}}